Ozarelix (D-63153) is a GnRH antagonist. Ozarelix induces cell apoptosis and arrests cell in G2/M phase. Ozarelix can be used in the research of prostate cancer[1].
Molecular Weight:
1459.09
CAS Number:
[295350-45-7]
Formula:
C72H96ClN17O14
Target:
Apoptosis,GnRH Receptor
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted